v3.26.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
CURRENT ASSETS    
Cash and cash equivalents $ 5,092 $ 4,353
Accounts receivable, net of allowance for credit loss reserve, $21 and $10 as of June 30, 2026 and December 31, 2025, respectively 558 857
Note receivable, net of allowance for credit loss reserve, $0 and $12 as of June 30, 2026 and December 31, 2025, respectively 1,988
Unbilled revenue 290 338
Prepaid expenses and other current assets 168 154
Inventory 41 37
TOTAL CURRENT ASSETS 6,149 7,727
PROPERTY AND EQUIPMENT, NET 13 20
INTANGIBLE ASSETS, NET 2,304 2,345
GOODWILL 2,926 2,926
TOTAL ASSETS 11,392 13,018
CURRENT LIABILITIES    
Accounts payable 342 745
Other accrued expense 331 530
Convertible note – related party, current 400 400
Convertible note, current 350 350
TOTAL CURRENT LIABILITIES 1,423 2,025
TOTAL LIABILITIES 1,423 2,025
STOCKHOLDERS' EQUITY    
Common stock, $0.001 par value; 675,000,000 shares authorized; 13,626,076 and 13,553,049 shares issued, 13,165,196 and 13,071,601 shares outstanding as of June 30, 2026 and December 31, 2025, respectively 14 14
Additional paid in capital 102,192 102,059
Treasury stock at cost; 460,880 and 481,448 shares at June 30, 2026 and December 31, 2025, respectively (475) (502)
Accumulated deficit (91,762) (90,578)
STOCKHOLDERS' EQUITY 9,969 10,993
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 11,392 13,018
Series A Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Convertible preferred stock
Series B Preferred Stock [Member]    
STOCKHOLDERS' EQUITY    
Convertible preferred stock